Current Status of Long-Acting Antiretroviral Therapy – from Evidence to the Guidelines to the Future - N Ndwapi.pdf

INTEREST 2023

Biological markers predictive of the risk of progression from hepatitis B virus infection to hepatocellular carcinoma in Senegal

INTEREST 2020

Perspective from Payers - Mel Krajden, MD, FRCPC & Bonnie Henry, MD, MPH, FRCPC

International Hepatitis Cure & Eradication Meeting 2015

Community HIV Testing Services: Experience from Targeted Testing of Under-served Men in Nigeria

INTEREST 2020

Prevalence of Hepatitis among the general population in Botswana from the STI microbial survey of 2017/2018

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Lessons Learned From Using a Commercial Activity Tracker to Measure Exercise in People Living With HIV

International Workshop on HIV & Aging 2020

Incidence and residual risk of HCV in Lithuanian blood donors from 2004 to 2018: call for screening improvement in a general population

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

A Novel Approach Continuum from Identification to Elimination in HCV-Infected Individuals on Opioid Substitution Therapy and High-Risk Populations

International Viral Hepatitis Elimination Meeting (IVHEM) 2020

Creating a Safe Space for Key Populations Within Health Facilities: Experience from Montserrado County, Liberia - Gift Kamanga

INTEREST 2020

Early life developmental trajectories of HIV exposed uninfected children – Results from a longitudinal study in Limpopo, South Africa.

International Workshop on HIV Pediatrics 2020